SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                    FORM 8-K


                Current Report Pursuant to Section 13 or 15(d) of
                       the Securities Exchange Act of 1934



       Date of Report (Date of earliest event reported): November 10, 2003
                                                         -----------------



                        Blonder Tongue Laboratories, Inc.
             ------------------------------------------------------
             (Exact Name of registrant as specified in its charter)



         Delaware                         1-14120                  52-1611421
--------------------------------   ------------------------    ---------------
(State or other jurisdiction of    (Commission File Number)   (I.R.S. Employer
         incorporation)                                      Identification No.)



                One Jake Brown Road, Old Bridge, New Jersey 08857
                -------------------------------------------------
               (Address of principal executive offices) (Zip Code)


       Registrant's telephone number, including area code: (732) 679-4000
                                                           --------------

                                 Not Applicable
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)


Item 7.  Financial Statements and Exhibits
         ---------------------------------

     (a)  Not applicable


     (b)  Not applicable


     (c)  The following exhibits are filed herewith:


     Exhibit 99.1   Press Release dated November 10, 2003.


Item 12.  Results of Operations and Financial Condition
          ---------------------------------------------

     On November 10, 2003,  the Company  issued a press release  announcing  its
unaudited  financial  results for the third quarter ended  September 30, 2003. A
copy of the press  release is  attached  to this  Report as Exhibit  99.1 and is
incorporated herein by reference.

                                       2


                                    SIGNATURE


     Pursuant to the  requirements  of the Securities  Exchange Act of 1934, the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned hereunto duly authorized.

                                        BLONDER TONGUE LABORATORIES, INC.



                                        By: /s/ Eric Skolnik
                                           -------------------------------------
                                           Eric Skolnik
                                           Chief Financial Officer

Date: November 10, 2003





                                       3